Anke E Kip

722 total citations
16 papers, 374 citations indexed

About

Anke E Kip is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Organic Chemistry. According to data from OpenAlex, Anke E Kip has authored 16 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 12 papers in Epidemiology and 7 papers in Organic Chemistry. Recurrent topics in Anke E Kip's work include Research on Leishmaniasis Studies (13 papers), Trypanosoma species research and implications (12 papers) and Synthesis and Biological Evaluation (7 papers). Anke E Kip is often cited by papers focused on Research on Leishmaniasis Studies (13 papers), Trypanosoma species research and implications (12 papers) and Synthesis and Biological Evaluation (7 papers). Anke E Kip collaborates with scholars based in Netherlands, Switzerland and Kenya. Anke E Kip's co-authors include Thomas P. C. Dorlo, Jos H. Beijnen, Jan H.M. Schellens, Hilde Rosing, Monique Wasunna, Fabiana Alves, Manica Balasegaram, María Adelaida Gómez, Peter J. de Vries and María del Mar Castro and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Anke E Kip

16 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anke E Kip Netherlands 11 251 184 71 62 61 16 374
Mohammad Asad India 10 176 0.7× 108 0.6× 53 0.7× 36 0.6× 30 0.5× 21 267
Laura Ramírez Brazil 14 314 1.3× 232 1.3× 86 1.2× 81 1.3× 29 0.5× 26 426
Shubhankar Kumar Singh India 14 327 1.3× 186 1.0× 117 1.6× 59 1.0× 33 0.5× 39 425
Edite H. Yamashiro-Kanashiro Brazil 11 152 0.6× 145 0.8× 45 0.6× 30 0.5× 20 0.3× 23 290
Sabrina Newman United States 5 266 1.1× 134 0.7× 27 0.4× 55 0.9× 51 0.8× 11 348
Kárita Cláudia Freitas Lidani Brazil 9 345 1.4× 463 2.5× 81 1.1× 99 1.6× 83 1.4× 29 624
K. C. Carter United Kingdom 11 268 1.1× 159 0.9× 39 0.5× 59 1.0× 77 1.3× 12 335
Vishal Goyal India 9 253 1.0× 194 1.1× 19 0.3× 50 0.8× 66 1.1× 26 390
Juan P. Macêdo Switzerland 9 186 0.7× 142 0.8× 42 0.6× 50 0.8× 29 0.5× 12 294
Vidya Nand Ravi Das India 10 238 0.9× 171 0.9× 52 0.7× 65 1.0× 22 0.4× 20 298

Countries citing papers authored by Anke E Kip

Since Specialization
Citations

This map shows the geographic impact of Anke E Kip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke E Kip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke E Kip more than expected).

Fields of papers citing papers by Anke E Kip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke E Kip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke E Kip. The network helps show where Anke E Kip may publish in the future.

Co-authorship network of co-authors of Anke E Kip

This figure shows the co-authorship network connecting the top 25 collaborators of Anke E Kip. A scholar is included among the top collaborators of Anke E Kip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke E Kip. Anke E Kip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Beliën, Jeroen A.M., Anke E Kip, & Morris A. Swertz. (2022). Road to FAIR genomes: a gap analysis of NGS data generation and sharing in the Netherlands. PubMed. 6(1). e100268–e100268. 3 indexed citations
2.
Kip, Anke E, Séverine Blesson, Fabiana Alves, et al.. (2021). Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study. Journal of Antimicrobial Chemotherapy. 76(5). 1258–1268. 7 indexed citations
3.
Verrest, Luka, Anke E Kip, Ahmed Musa, et al.. (2021). Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa. Clinical Infectious Diseases. 73(5). 775–782. 19 indexed citations
4.
Kip, Anke E, Gerben M. Franssen, Egbert Oosterwijk, et al.. (2020). Therapeutic efficacy and tolerability of [225Ac]Ac-DOTA-hG250 targeted alpha therapy in a clear cell renal cell carcinoma mice model. European Urology Open Science. 19. e1482–e1482. 1 indexed citations
5.
Kip, Anke E, Jos H. Beijnen, Jane Mbui, et al.. (2020). Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa. Journal of Antimicrobial Chemotherapy. 75(11). 3260–3268. 10 indexed citations
6.
Kip, Anke E, Monique Wasunna, Fabiana Alves, et al.. (2018). Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology. 8. 181–181. 16 indexed citations
7.
Kip, Anke E, María del Mar Castro, María Adelaida Gómez, et al.. (2018). Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure–response relationships. Journal of Antimicrobial Chemotherapy. 73(8). 2104–2111. 10 indexed citations
8.
Mbui, Jane, Joseph Olobo, Raymond Omollo, et al.. (2018). Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial. Clinical Infectious Diseases. 68(9). 1530–1538. 37 indexed citations
9.
Kip, Anke E, Jan H.M. Schellens, Jos H. Beijnen, & Thomas P. C. Dorlo. (2017). Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs. Clinical Pharmacokinetics. 57(2). 151–176. 55 indexed citations
10.
Dorlo, Thomas P. C., Anke E Kip, Brima M. Younis, et al.. (2017). Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study. Journal of Antimicrobial Chemotherapy. 72(11). 3131–3140. 25 indexed citations
11.
Kip, Anke E, et al.. (2016). Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples. Journal of Pharmaceutical and Biomedical Analysis. 135. 160–166. 69 indexed citations
12.
Gregory, David J., et al.. (2016). Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages. Journal of Biological Chemistry. 291(18). 9638–9647. 8 indexed citations
13.
Kip, Anke E, Hilde Rosing, M. J. X. Hillebrand, et al.. (2016). Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection. Antimicrobial Agents and Chemotherapy. 60(4). 2081–2089. 16 indexed citations
14.
Castro, María del Mar, María Adelaida Gómez, Anke E Kip, et al.. (2016). Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis. Antimicrobial Agents and Chemotherapy. 61(3). 41 indexed citations
15.
Kip, Anke E, Hilde Rosing, M. J. X. Hillebrand, et al.. (2015). Quantification of miltefosine in peripheral blood mononuclear cells by high-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B. 998-999. 57–62. 12 indexed citations
16.
Kip, Anke E, Manica Balasegaram, Jos H. Beijnen, et al.. (2014). Systematic Review of Biomarkers To Monitor Therapeutic Response in Leishmaniasis. Antimicrobial Agents and Chemotherapy. 59(1). 1–14. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Asad Breakdown of academic impact, for papers by Laura Ramírez Breakdown of academic impact, for papers by Shubhankar Kumar Singh Breakdown of academic impact, for papers by Edite H. Yamashiro-Kanashiro Breakdown of academic impact, for papers by Sabrina Newman Breakdown of academic impact, for papers by Kárita Cláudia Freitas Lidani Breakdown of academic impact, for papers by K. C. Carter Breakdown of academic impact, for papers by Vishal Goyal Breakdown of academic impact, for papers by Juan P. Macêdo Breakdown of academic impact, for papers by Vidya Nand Ravi Das
Rankless by CCL
2026